Alzheimer's disease & dementia

Phase III aducanumab trials for Alzheimer's disease stopped early

Pharmaceutical companies Biogen and Eisai today (Thursday 21 March) announced they are to discontinue two phase III trials of the Alzheimer's drug aducanumab. The ENGAGE and EMERGE trials were designed to evaluate the efficacy ...

Medications

Making sense of the recent blood pressure drug recalls

(HealthDay)—People taking blood pressure medications have faced a frightening and bewildering series of pharmaceutical recalls in recent months, as trace amounts of cancer-causing chemicals have been discovered in individual ...

Medications

FDA warns 17 companies about illegal Alzheimer disease products

(HealthDay)—A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat, or cure Alzheimer disease and other serious conditions, the U.S. Food and Drug ...

page 36 from 40